$2.90 per share would value Pfizer stock at less than 9 times earnings, Pfizer pays a 6.5% dividend yield -- and hasn't cut ...
Pfizer (PFE) stock dips as the company projects a revenue decline for 2026 amid a nearly $1.5B impact attributed to patent ...
What Pfizer’s recent performance tells you right now Pfizer (PFE) has drawn fresh attention after a period in which the share ...
Pfizer is almost certain to survive the current headwinds as a business. However, the dividend may not. It will be important ...
Pharmaceutical giant Pfizer (PFE) released its fourth quarter earnings results that topped Wall Street's expectations on its ...
A long-acting shot Pfizer got through a buyout of Metsera appeared “slightly inferior” to Lilly’s market-leading Zepbound in a Phase 2 trial, one analyst said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results